Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Gut 2006;55:754-755; doi:10.1136/gut.2005.076067
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hornby, P J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hornby, P J
Topic Collections
Right arrowRelated Article

COMMENTARY

Ghrelin

Designing Spiegelmers to antagonise ghrelin

P J Hornby

Correspondence to:
Correspondence to:
Dr P J Hornby
Enterology Biology Team Leader, Johnson & Johnson, Research and Development L L C, UK; phornby@prdus.jnj.com


Use of an anti-ghrelin Spiegelmer could be an innovative new approach to inhibit the biological actions of circulating ghrelin

Keywords: ghrelin; obesity; antagonism; NOX-B11; food intake; rat

The first 150 words of the full text of this article appear below.

The article by Kobelt and colleagues1 in this issue of Gut, further explores a novel mechanism to interfere with the action of ghrelin on its receptor, growth hormone secretagogue receptor 1 (GHS-R) (see page 788). Ghrelin is a 28 amino acid peptide localised immunocytochemically in parietal cells of the human stomach2 where it is released and stimulates growth hormone release, food intake, and adiposity. Human plasma has relatively low levels of ghrelin3 although, somewhat counter intuitively, in anorectic patients the fasting level of ghrelin, including the active form (n-octanoyl modification at serine 3), is significantly higher.4 The main impact of this work is that the investigators have demonstrated the efficacy of and dose related inhibition of ghrelin stimulated food intake in rats. They did this by using a biological approach to bind to ghrelin and prevent the interaction of ghrelin with its receptor in . . . [Full text of this article]


Related Article

Anti-ghrelin Spiegelmer NOX-B11 inhibits neurostimulatory and orexigenic effects of peripheral ghrelin in rats
P Kobelt, S Helmling, A Stengel, B Wlotzka, V Andresen, B F Klapp, B Wiedenmann, S Klussmann, and H Mönnikes
Gut 2006 55: 788-792. [Abstract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology